Delivery Order SPE2DB25D3003-SPE2DB25FPVND

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award has been granted to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is for the delivery of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription medication, to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract, valued at $1,741.68, is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,237.04, is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price delivery order. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,201.20, is a Firm Fixed Price Delivery Order for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has an ultimate completion date of January 7, 2025. This award is under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $4,376.73 for the supply of the medication Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The award has an ultimate completion date of January 8, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pen. The contract is a delivery order with a firm-fixed price pricing type and a ceiling value of $26,720.40. It has an ultimate completion date of December 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The $8,803.28 firm fixed-price contract has a performance period ending on July 25, 2024. The contract is not set aside for any designated socioeconomic program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pens. The contract has a ceiling value of $6,594.60 and a completion date of November 15, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $11,611.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication Trulicity, a 3 mg/0.5 ml pen with a 0.5 ml dosage. The contract has a completion date of January 18, 2024 and is structured as a Firm Fixed Price Delivery Order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract, valued at $5,673.54, is a delivery order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,038.03, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. The award did not utilize a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPVND
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,327.06, is for the delivery of the medication Trulicity 1.5 mg/0.5 ml pen 0.5ml. The contract has an ultimate completion date of January 13, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 4/13/25, 12:54 AM